Anti-inflammatory effect of bergamot leaves extract attenuates cardiac remodeling in obese rats by regulating the protein expression of the collagen/metalloproteinase axis
Inflammation is associated with the pathogenesis of obesity-related disorders, including cardiac remodeling. Bergamot is known for its promising anti-inflammatory effects. Thus, this study aimed to investigate the anti-inflammatory effect of bergamot leaves extract (BLE) in attenuating cardiac remodeling in obese rats through the regulation of protein expression of the collagen/metalloproteinase axis. Male Wistar rats were fed a control diet (C) or a high sugar-fat diet (HSF) for 20 weeks. After developing cardiac remodeling, the animals were again distributed into three groups to receive BLE (50 mg/kg/day) or placebo (water) via gavage for 10 weeks: C, HSF and HSF + BLE. The HSF group exhibited obesity (HSF 8.77 ± 2.64 vs C 3.09 ± 1.02, p = 0.007), dyslipidemia (HSF 94.4 ± 19.1 vs C 26.7 ± 5.2, p < 0.001), hypertension (HSF 141 ± 8 vs C 120 ± 4, p = 0.001), insulin resistance (HSF 6.91 ± 1.38 vs C 2.47 ± 1.01, p < 0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 vs C 0.71 ± 0.07, p = 0.009) and increased type III collagen (HSF 1.32 ± 0.27 vs C 1.00 ± 0.18, p = 0.038). In contrast, BLE was effective in improving dyslipidemia (HSF + BLE 55.2 ± 9.7 vs HSF 94.4 ± 19.1, p < 0.001), insulin resistance (HSF + BLE 3.79 ± 0.76 vs HSF 6.91 ± 1.38, p < 0.001), cardiac remodeling and function, as well as inflammation, MMP-2 (HSF + BLE 0.84 ± 0.22 vs HSF 0.43 ± 0.09, p < 0.001) and type III collagen (HSF + BLE 0.68 ± 0.11 vs HSF 1.32 ± 0.27, p < 0.001) in the HSF group. Therefore, the anti-inflammatory effect of BLE improved cardiac remodeling in obese rats through the regulation of protein expression of the collagen/metalloproteinase axis.
Authors
- Lílian Cristina Pereira (ORCID: https://orcid.org/0000-0003-0024-7655)
- Juliana Silva Siqueira (ORCID: https://orcid.org/0000-0003-3172-2199)
- Fabiane Valentini Francisqueti‐Ferron (ORCID: https://orcid.org/0000-0003-2910-4308)
- Giovanna Baron (ORCID: https://orcid.org/0000-0002-9335-6318)
- Silméia Garcia Zanati Bazan (ORCID: https://orcid.org/0000-0002-0607-8189)
- Dijon Henrique Salomé de Campos (ORCID: https://orcid.org/0000-0002-4933-0604)
- Erika Tiemi Nakandakare-Maia (ORCID: https://orcid.org/0000-0003-1253-001X)
- Camila Renata Corrêa (ORCID: https://orcid.org/0000-0001-8493-5329)
- Marina Gaiato Monte (ORCID: https://orcid.org/0000-0003-4060-870X)
- Francis Lopes Pacagnelli (ORCID: https://orcid.org/0000-0003-3712-5854)
- Giancarlo Aldini (ORCID: https://orcid.org/0000-0002-2355-6744)
- Taynara Aparecida Vieira (ORCID: https://orcid.org/0000-0002-5312-0060)
- Marina Politi Okoshi (ORCID: https://orcid.org/0000-0001-7728-4505)
- Núbia Alves Grandini (ORCID: https://orcid.org/0000-0002-1696-4993)
- Artur Júnio Togneri Ferron (ORCID: https://orcid.org/0000-0001-7089-3033)
Institutions
- University of Milan (IT)
- Universidade do Oeste Paulista (BR)
- Instituição Toledo de Ensino (BR)
- Universidade Estadual Paulista (Unesp) (BR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1371/journal.pone.0334015
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00